CRC Credit Research Compendium
Menu
日本語English

Issuer Credit Research

Issuer Flash: Sammaan Capital Limited — Q1 FY2027 Results

Issuer: Sammaan Capital | Document: Issuer Flash | Date: 2026-08-20 | Event: Q1fy2027 Results

Report date: 2026-08-20 Event date: 2026-08-13 Event title: Q1 FY2027 Results

1. Flash Conclusion

Sammaan Capital's first reported quarter after the FY2026 legacy-book clean-up provides encouraging, but not yet conclusive, evidence that its recapitalised franchise can again generate profit. Consolidated profit after tax was Rs.243.30 crore in the quarter ended 30 June 2026, while standalone capital, liquidity and reported asset-quality ratios were stronger than the loss-affected FY2026 starting point: CRAR was 20.06%, the liquidity coverage ratio (LCR) was 127%, and standalone GNPA and NNPA were 0.22% and 0.17%, respectively. The quarterly result therefore supports the existing view that IHC/Avenir sponsorship and the preceding clean-up have created a more credible platform for recovery.

The disclosure also contains a material qualification for creditors. The auditors' asset-cover certificate says that the company had breached certain financial covenants under borrowing arrangements other than the listed debentures it examined. The certificate says that the breaches did not cause non-compliance with Regulation 54 asset-cover requirements or the covenants applicable to the covered debentures, and that the sampled debenture trust deeds did not contain a cross-default triggered by those breaches. That is constructive for the specified debentures, but it is not equivalent to a clean bill of health for all funding arrangements. The facilities concerned, amounts, lenders, waiver status and cure timetable were not disclosed.

Accordingly, the flash leaves the credit view at sponsor-supported reconstruction NBFC, with early operating stabilisation but still elevated execution and funding-documentation risk. The Q1 profit, regulatory ratios and debt-management actions are positive evidence. They do not by themselves establish that earnings are normalised, that legacy-risk resolution is complete, or that covenant risk has been eliminated.

2. Q1 Results and Post-Clean-Up Metrics

The 13 August NSE/BSE filing contains unaudited standalone and consolidated results subject to a limited review by the joint statutory auditors. Consolidated total income was Rs.1,682.81 crore, compared with Rs.2,409.43 crore in Q1 FY2026, and PAT was Rs.243.30 crore, compared with a Rs.8,101.41 crore loss in Q4 FY2026 and Rs.334.30 crore PAT in Q1 FY2026. Standalone PAT was Rs.225.60 crore, down from Rs.297.44 crore a year earlier. The comparison with Q4 is necessarily distorted by the prior quarter's large impairment and exceptional-loss recognition, so the return to profit should be read as an early stabilisation indicator rather than a normalised run-rate conclusion.

Metric Q1 FY2027 / 30 Jun 2026 Credit read-through
Consolidated total income Rs.1,682.81 crore Lower than Q1 FY2026; the filing does not provide a full adjusted earnings bridge.
Consolidated finance costs Rs.1,335.26 crore Funding cost remains a central earnings and refinancing variable.
Consolidated impairment Rs.(240.47) crore Net write-back supports quarterly profit, but should not be treated as recurring without later-period evidence.
Consolidated PAT Rs.243.30 crore Positive after the FY2026 clean-up loss, but below Q1 FY2026 PAT.
Standalone debt/equity 2.23x A reported capital-structure metric; comparison should use the same disclosure basis.
Standalone CRAR / LCR 20.06% / 127% Provides a regulatory capital and liquidity buffer at the reporting date.
Standalone GNPA / NNPA 0.22% / 0.17% Low reported ratios, but Stage 2, ECL, collection and maturity detail remains necessary for a fuller view.
Total standalone financial indebtedness Rs.44,719.64 crore Reinforces the need to assess funding terms, maturity profile and covenant architecture rather than ratios alone.

The filing also reports new disclosures that are relevant to the legacy-book and portfolio-transition narrative. During the quarter, the company transferred six stressed-loan accounts with aggregate principal outstanding of Rs.99.67 crore; it states that aggregate consideration was Rs.96.01 crore. It also reported Rs.278.16 crore of purchase consideration from assignment of written-off loans. These are discrete portfolio-management data points, not proof that all legacy-risk exposures are resolved. The filing does not supply a complete period-on-period Stage 2/Stage 3, ECL, recovery or loss-given-default bridge.

3. Funding, Bondholder Protections and the Covenant Disclosure

The company bought back US$45m principal amount of its US$450m 7.5% senior secured social bonds due 2030 during the quarter. It also disclosed a subsequent buyback of US$18m of its US$350m 9.70% senior secured social bonds due 2027, and the July 2026 allotment of Rs.1,400 crore of secured, rated, listed NCDs. The NCD allotment demonstrates completion of a secured listed-debt funding transaction, while its pricing, tenor, investor base, security package and implications for refinancing capacity remain unconfirmed. The bond repurchases can reduce outstanding external debt, but their net liquidity effect is also not disclosed. Those points remain important because a non-bank lender does not have a deposit franchise and is inherently more dependent on wholesale funding confidence.

The covenant disclosure deserves separate treatment. The asset-cover certificate says that certain borrowing-arrangement covenants had been breached at 30 June 2026. The same certificate states that this did not result in non-compliance with the asset-cover requirements for the listed debentures or their applicable covenants, and that sampled trust deeds did not contain a cross-default that would be triggered. This is a credit positive boundary around the listed-debenture analysis, but its scope is limited. The certificate does not identify the facilities, state whether waivers were obtained, quantify the breach or explain the path to cure. It also notes that its covenant procedures were performed on a sample basis. Bondholders should therefore avoid extrapolating the finding to every NCD, bank facility, social bond or other obligation.

4. Credit Read-Through

The results reinforce the distinction made in the May issuer summary between sponsor support and standalone demonstrated performance. The reported 20.06% CRAR, 127% LCR and low GNPA/NNPA are positive reported indicators at 30 June 2026, but the filing does not provide regulatory-minimum comparisons, a detailed ALM profile, liquidity composition, or the full ECL and asset-quality bridge needed to assess their durability. The return to profit and debt buybacks are also consistent with improved financial flexibility after the IHC/Avenir investment.

At the same time, the Q1 earnings mix cautions against a broad upgrade in the analytical stance. A net impairment write-back contributed to the quarter, while total income and PAT were below the year-earlier quarter. The result is not enough to establish a durable earnings trajectory or to validate the long-term performance of the post-clean-up book. The company continues to report finance and mortgage-backed lending as its core activity, and its credit quality remains sensitive to collection performance, collateral values, wholesale refinancing, ALM and the treatment of residual legacy exposures.

The covenant disclosure is the most important new downside item. It does not indicate a default of the covered debentures based on the issuer's certificate, but it shows that the company still has facility-specific terms that need to be understood. Until the relevant contracts, waivers and cure status are available, creditors should treat the result as improved operating evidence within an incomplete liability-side picture. IHC/Avenir's promoter position and board representation remain positive support factors, but the disclosure does not create an explicit sponsor guarantee or alter the legal ranking of individual debt instruments.

5. What To Watch Next

6. Sources